Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...

SOUTH SAN FRANCISCO, Calif., Oct. 04, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming ...

A new form of cancer treatment for melanoma patients has been approved by the FDA, after a clinical trial in St. Louis showed ...

The United States market has been flat over the last week, but it has seen a significant rise of 34% over the past 12 months, with earnings forecasted to grow by 15% annually. In this context, ...

Researchers at the Spanish National Cancer Research Center (CNIO) propose a new treatment for brain metastases that respond ...

In a pioneering study that bridges the gap between science fiction and reality, researchers have unveiled an innovative ...